Bayer AG (FRA:BAYN) Given a a 106.00 Price Target at Nord/LB
The firm presently has a "neutral" rating on the healthcare company's stock. Other research analysts also recently issued research reports about the company.
from Biotech News
The firm presently has a "neutral" rating on the healthcare company's stock. Other research analysts also recently issued research reports about the company.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments